| 000 | 01904 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517090959.0 | ||
| 264 | 0 | _c20171226 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.8609 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColeman, David T | |
| 245 | 0 | 0 |
_aRepurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation. _h[electronic resource] |
| 260 |
_bOncotarget _cMay 2016 |
||
| 300 |
_a32200-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 |
_aCancer-Associated Fibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Glycosides _xpharmacology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Shape _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Repositioning |
| 650 | 0 | 4 |
_aFibronectins _xmetabolism |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyofibroblasts _xdrug effects |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSmad Proteins _xgenetics |
| 650 | 0 | 4 | _aSmall Molecule Libraries |
| 650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 650 | 0 | 4 | _aTumor Microenvironment |
| 700 | 1 | _aGray, Alana L | |
| 700 | 1 | _aStephens, Charles A | |
| 700 | 1 | _aScott, Matthew L | |
| 700 | 1 | _aCardelli, James A | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 22 _gp. 32200-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.8609 _zAvailable from publisher's website |
| 999 |
_c25906592 _d25906592 |
||